Crossmark

Young Investigator Award 2026: Extent and incidence of pseudo-worsening of kidney function due to oral antitumor therapeutics in the AMBORA cohort: an analysis of real-world data

Crossref DOI link: https://doi.org/10.1007/s00210-026-05651-9

Published Online: 2026-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sponfeldner, Michael I. https://orcid.org/0009-0000-8236-0074
Funding

Funding for this research was provided by:

Friedrich-Alexander-Universität Erlangen-Nürnberg
License Information

Text and Data Mining valid from 2026-07-01

Version of Record valid from 2026-07-01
More Information

Article History

Received: 23 June 2026

Accepted: 24 June 2026

First Online: 1 July 2026

Declarations

:

: Parts of this work were presented at the 10th German PharmTox Summit in Hannover (March 26-28, 2025, Hannover, Germany) and the EACPT 2025 Congress in Helsinki (June 28 – July 1, Helsinki, Finland).

: The author declares no competing interests.

Document is current

Any future updates will be listed below